Dead Cells: The Queen And The Sea if its not the last DLC after all, then all the better (pic: Motion Twin)
The third, but not necessarily final, paid-for DLC for Dead Cells is the first major release of 2022 and just as good as youd expect.
Way back in the early history of video games there was a game called Rogue. Released in 1980, it was a dungeon crawler where each time you died you started again at the beginning, right from scratch. Its the kind of brutality players modern players arent used to but its design choices have inspired numerous developers since the turn of the millennium, giving birth to the still popular roguelike genre.
Even though Dead Cells, which received its most recent piece of DLC this month, is a roguelike, it also has strong Metroidvania leanings. Like its namesakes, Metroid and Castlevania, new powers and equipment let you reach previously inaccessible areas in levels youve already played. Its a way of hiding secrets in plain sight, tempting you to progress so you can explore areas that you could see, but that remained tantalisingly out of reach.
In 2017, when Dead Cells entered early access on Steam, players discovered a small, tightly designed 2D Metroidvania game, with short levels, pixel perfect animation, and a roguelike keenness to teach you through repeatedly killing you. Little did anyone know, least of all developer Motion Twin, that the coming five years would see the game morph into a six million selling behemoth.
Each of Dead Cells immaculate, procedurally generated levels comprises its own biome, complete with their own delightful parallax scrolling backgrounds, scenery, and enemies. Feeling your way around the map, you soon find out which biome leads where, letting you plan a route through areas and past enemies that you at least have a chance of beating.
Before it entered full release in 2018, the original Dead Cells had already gained the Time Keeper boss as DLC, as well as the Slumbering Sanctuary biome and the dreaded Forgotten Sepulchre, a level shrouded in a darkness that will kill your character a nameless, headless former prisoner if hes left exposed to it for too long. It also gained mutations, the games perk system that you unlock in the corridor-like anterooms that preface each biome.
The final pre-launch innovation was the addition of boss stem cells, which you earn by defeating the Hand of the King, the games final boss. Each stem cell cranks up the difficulty, reshuffles the connections between levels, and most significantly, alters the enemies you face in each area. Stem cells not only keep the game fresh but add a degree of challenge that gives Dead Cells a longevity measured in hundreds of hours.
Since then, the updates have arrived thick and fast. Fresh biomes, new enemies, more weapons, bigger bosses, different mutations, and continual rounds of nerfs and buffs to maintain balance amongst the games rapidly expanding bestiary and armoury. Always engaged with the games obsessive fanbase, the developers have ensured the onslaught of new material, and frequently requested quality of life improvements, has never let up.
Perhaps the most surprising element of all this is that almost every update and DLC has been delivered free. Even post-2019, when development switched to Evil Empire, a spin-off studio formed specifically to support the title, only two of its DLCs have been paid-for, a sustained feat of generosity rarely matched in the modern era.
The latest update, The Queen And The Sea, is only the third one you have had to pay for, and is intended as the finale of the narrative arc that runs between all three paid-for expansions.
After downloading it, a tentacle drops off a letter right at the beginning of Prisoners Quarters, the games first level, acting as a signpost for a set of clues that will lead you to a giant, heavily armoured prawn who gives you possibly the updates most powerful weapon: the Leghugger, a sidekick that feeds on enemies, eventually eating enough of them to evolve into its even more powerful adult state.
The armoured shrimp also leaves you a key to the Lighthouse, which pops open a door in the last level, High Peak Castle, where you can set sail for the Infested Shipwreck, the first of two new biomes. Its here that youll discover not all adult Leghuggers are friendly, some in fact want to eat you just as much as your new buddy enjoys devouring foes.
Make it through the Shipwreck and youll face the new boss, The Queen. She starts by chasing you up through the rickety structure of the Lighthouse, which is consumed by flames in her wake, meaning speed is very much of the essence. Get to the top and its time to fight her, replacing the final battle with the Hand of the King.
Along with the new boss and biomes come a slew of new weapons, from the Maw of the Deep (a shark you use to swing at enemies before hurling it at them jaws first) to the Hand Hook (a distinctly pirate-y way to lay waste to foes) and the Scavenged Bombard (a squat little cannon that does a lot of damage, but only works when youre standing right next to it).
The sheer number of possible routes enabled by the procedural generation, and the multiplicity of final bosses make, ensures that Dead Cells is a different game every time you play it. Thats something thats only slightly attenuated by using Custom Mode, which lets you exclude weapons, powers, and mutations you dont fancy using.
Although Motion Twin hasnt said what its paid-for plans are beyond The Queen And The Sea, it has already promised lots more free DLC throughout 2022 which suggests an embarrassment of riches without paying a penny more. After more than three years of non-stop development, Dead Cells stands as one of the best indie games of all time and its only getting better.
In Short: Motion Twins winning take on 2D Metroidvania roguelikes is kept alive by another excellent DLC expansion.
Pros: Two well designed new levels to explore, one of which is completely different from anything thats come before, adds fresh routes through the game and a new final battle.
Cons: If you dont enjoy the punishing nature of roguelikes, or ultra-fast 2D actioners, this is unlikely to dissuade you from that view.
Score: 9/10
Formats: PlayStation 4 (reviewed), Xbox One, Nintendo Switch, PC, iOS, and AndroidPrice: 3.99 (9.49 for all three paid-for DLCs or 26.99 with base game as well)Publisher: Motion TwinDeveloper: Evil EmpireRelease Date: 6th January 2022Age Rating: 16
By Nick Gillett
Email gamecentral@metro.co.uk, leave a comment below, and follow us on Twitter.
MORE : Dead Cells: Fatal Falls DLC review falling in love again
MORE : Dead Cells: The Bad Seed DLC review growing content
MORE : Dead Cells review random inspiration
Follow Metro Gaming on Twitter and email us at gamecentral@metro.co.uk
For more stories like this,check our Gaming page.
Read the original:
Dead Cells: The Queen And The Sea DLC review - water ending - Metro.co.uk
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
- NOT-AR-23-022: Request for Information on Themes for the NIAMS ... - National Institutes of Health (.gov) - December 3rd, 2023
- December 2023: Intramural Papers of the Month - Environmental Factor Newsletter - December 1st, 2023
- CNA Explains: What is cord blood banking and why do parents do it? - CNA - December 1st, 2023
- Regulation of myogenesis and adipogenesis by the electromagnetic ... - Nature.com - December 1st, 2023
- The effects of vitamin K on bone health - News-Medical.Net - December 1st, 2023
- Dr Hurwitz on Ongoing Investigations of the Use of CAR T-Cell ... - OncLive - December 1st, 2023
- Mitophagy in human health, ageing and disease - Nature.com - December 1st, 2023
- Adult Stem Cells - Stem Cells and the Future of Regenerative Medicine ... - November 29th, 2023
- Navigating The Regulatory Landscape Of Longevity Health Products ... - Mondaq News Alerts - November 29th, 2023
- MS breakthrough could lead to treatments that halt disease's ... - inews - November 29th, 2023
- Reprogramming tissue mechanically to promote wound healing - Phys.org - November 29th, 2023
- Latest Advances in Arthritis Diagnosis and Treatment at American ... - HealthDay - November 29th, 2023
- Sex-associated differences in frequencies and prognostic impact of ... - Nature.com - November 29th, 2023
- Hematologists Dive into the Current Treatment Landscape - OncLive - November 29th, 2023
- Team discovers protein crucial for B cell differentiation and antibodies - Phys.org - November 29th, 2023
- Science Talk - I survived cancer as a child and now I'm working to ... - The Institute of Cancer Research - November 29th, 2023
- First Edition: Nov. 29, 2023 - KFF Health News - November 29th, 2023
- Symptoms: Unilateral Hearing Loss and Tinnitus : The Hearing Journal - LWW Journals - November 29th, 2023
- Mitigation of sepsis-induced acute lung injury by BMSCs | IJN - Dove Medical Press - November 29th, 2023
- A Case of a Constricted Vessel: The Impact of Acute Myeloid ... - Cureus - November 29th, 2023
- Mum brushed off fatigue after having baby but fall sparked deadly diagnosis - The Mirror - November 29th, 2023
- How heritable is the epigenome? - Drug Discovery News - November 29th, 2023
- The Blueprint of Regeneration: Scientists Discover How to Turn Stem Cells Fate - Revyuh - November 27th, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - Marketscreener.com - November 27th, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - PharmiWeb.com - November 25th, 2023
- COVID-19 Pandemic's Adverse Effect on Bone Health in Young ... - HealthDay - November 25th, 2023
- Sickle cell breakthrough - The Indian Express - November 25th, 2023
- Wall thickness analysis method for judging the degree of lower ... - Nature.com - November 25th, 2023
- Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference - Yahoo Finance - November 23rd, 2023
- Disease Transmission and Diagnosis of Zika Virus - Cureus - November 23rd, 2023
- Gene-editing therapy for sickle cell earns conditional approval in UK - Sickle Cell Disease News - November 23rd, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - Newswire - November 21st, 2023
- Efficacy of ADSC-CM in Patients with Telogen Effluvium | SCCAA - Dove Medical Press - November 21st, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - PR Newswire - November 21st, 2023
- The Impact of CAR T Cell Therapy on Managing R/R LBCL - OncLive - November 21st, 2023
- Mansour bin Zayed witnesses inauguration of ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2023 - ZAWYA - November 21st, 2023
- Listeria: Who is most susceptible? What are the Symptoms? What ... - Food Poison Journal - November 21st, 2023
- Scope Of Issued Patents May Be Limited By Prosecution Estoppel ... - Mondaq News Alerts - November 21st, 2023
- Qrons Announces the Addition of Professor Shiri Navon-Venezia to ... - StreetInsider.com - November 21st, 2023
- Financially strapped Athersys raises $10.4M - cleveland.com - November 19th, 2023
- From the India Today archives (2010) | How stem cells can save your life - India Today - November 19th, 2023
- Inactivation of the tumor suppressor gene Apc synergizes with H ... - Science - November 19th, 2023
- The Origins of Multiple Myeloma and Why it Matters - HealthTree For AML - Acute Myeloid Leukemia - November 19th, 2023
- Treatment Considerations With TROP2-Targeted Therapy - OncLive - November 19th, 2023
- Athersys narrows loss, raises $10.4 million during third quarter to ... - The Business Journals - November 17th, 2023
- Who was Dolly the Sheep and what happened to her? The story of ... - BBC Countryfile Magazine - November 17th, 2023
- UK first to approve CRISPR treatment for diseases: what you need to ... - Nature.com - November 17th, 2023
- 1st sickle cell patient to be given therapy restoring fetal hemoglobin - Sickle Cell Disease News - November 15th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates - Century - Benzinga - November 13th, 2023
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer - Yahoo Finance - November 11th, 2023
- Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in... - November 11th, 2023
- AAO 2023: Paul Runge and his ROP treatments in the Ukraine - Modern Retina - November 11th, 2023
- The Evolutionary Reasons We Are Drawn To Horror Movies and ... - Slashdot - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - GlobeNewswire - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 9th, 2023
- NYU Langone Health Performs World's First Whole-Eye & Partial ... - NYU Langone Health - November 9th, 2023
- BrainStorm to Announce Third Quarter 2023 Financial Results and ... - BioSpace - November 9th, 2023
- Can we cut cost and pain of IVF? Start-up CEO tries out own ... - Genetic Literacy Project - November 9th, 2023
- Jasper Therapeutics Reports Third Quarter 2023 Financial Results ... - BioSpace - November 9th, 2023
- Impaired neural stress resistance and loss of REST in bipolar ... - Nature.com - November 9th, 2023
- Functional genomics and systems biology in human neuroscience - Nature.com - November 9th, 2023
- Trial launched to test CAR T-cell therapy in dogs diagnosed with ... - EurekAlert - November 9th, 2023
- The-Gut's-Lasting-Impact-on-Severe-COVID-19-Immune-Response - Infectious Disease Special Edition - November 9th, 2023
- Emerging Cure for Sickle Cell on its Way to FDA Approval, Carries ... - Dallasweekly - November 7th, 2023
- The science works, but will we pay for it? - Irish Medical Times - November 7th, 2023
Recent Comments